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Helicobacter pylori is one of the most common human pathogens and since it was discovered 
in 1982 by Marshall and Warren has been established as one of the most variable and diverse 
bacteria known to man. Resident to the lining of the human stomach it is seen as the cause of 
a multitude of illnesses, ranging from mild gastritis, gastroduodenal ulcers as well as gastric 
cancer and controversially even heart disease. Some links have even been made to a 
protective function concerning people infected with Helicobacter pylori being less likely to 
suffer from GERD (gastro-esophageal reflux disease). The differentiation of a pathogen so 
prevalent and variable presents a challenge. To date two versions of Helicobacter pylori have 
been sequenced indicating an immense variability in its genetic makeup. Sequencing cannot 
however be effectively used to differentiate this bacterium in an everyday setting and is too 
cost- and time-intensive to describe the multitude of strains that have been found. PCR-RFLP 
(polymerase chain reaction used as amplification and restricted fragment length 
polymorphism used as differentiation method) is a tried and tested method of differentiating 
bacteria. We propose that from 37 Helicobacter pylori positive gastric biopsies and 33 viable 
PCR products the selection of two different genes (UreAB and UreCD) and consecutive PCR-
RFLP on these two genes (using HaeIII and NdeII respectively) is superior to PCR-RFLP on 
only one gene. After running the experiment we include an analysis of the resultant gel 
electrophoresis band patterns with GelComparII to our visual evaluation. We can demonstrate 
that the two combined PCR-RFLP runs are superior to both of the single runs with only one 
pair of Helicobacter pylori strains showing an identical band pattern in both UreAB/HaeIII 
and UreCD/NdeII runs. The ideal combination of differentiation methods and computing 
equipment would allow the construction of a database correlating pheno- and genotype. This 
would allow the clinician to make a more precise judgement on which patient it is necessary 








When confronted with Helicobacter pylori, the initial reaction is to state that it is a Gram-
negative, curved or spiral flagellated bacteria that inhabits the mucus layer of the human 
gastric epithelium (Marshall, 1989). This does not do Helicobacter pylori justice. More than 
just being a pathogen that has to be eliminated it offers researchers a unique opportunity to 
study the finely tuned interplay of the human body and an organism residing there within. 
It is commonly found in 30-90% of the population depending on socio-economic conditions 
and in all countries tested to date (Taylor et al., 1995). Being the cause of and associated with 
diseases such as duodenal ulcer, chronic active gastritis (Marshall et al., 1984), gastric cancer 
(Nomura et al., 1991), MALT-lymphoma (Wotherspoon et al., 1993) and controversially even 
ischemic heart disease (Mendall et al., 1994) it represents a challenge for the human body. 
Considering the abundance of infection and the relatively low count of illnesses it is 
associated with there must be some variables that account for the discrepancy. The following 
text is in the context of finding those variables. 
 
This introduction seeks to give a broad overview of the discovery of Helicobacter pylori, a 
description of the pathogen itself and to discuss its importance for the medical community, as 
well as highlight the goals of the research undertaken in this paper. 




Development of microscopic and consequently bacterial science brought about new areas of 
research. The presence of gastric spiral bacteria was first reported in 1893 by Bizzozero, an 
Italian physician. His research into the intestine of canines revealed the presence of spiral 
bacteria in the gastric mucosa, the presence of which was later supported by Solomon, who 
found similar bacteria in the stomachs of cats and mice. The first demonstration of these 
bacteria in human stomachs took place in 1906 and was done by Krienitz. He had been 
researching patients suffering from gastric carcinoma, in whose stomachs he commonly 
isolated the previously described bacteria. Nine years later spiral micro organisms in the 
stomachs of patients with gastric and duodenal ulcers were reported (Rosenow et al., 1915), 
but both he and Krienitz considered them to be contaminants to rather than the cause of those 
diseases. Bacteriology was still in its infancy at the time and penicillin not in common usage 
for many years to come and the cat of knowledge was pursued down different alleys. 
 
In 1938 spirochetes were found in 43% of 240 human and other primate stomachs after 
autopsy using a Haematoxylin-Eosin stain (Doenges et al., 1938), without deriving any 
association to an illness. This heightened interest in spiral bacteria brought forth another 
interesting article written only a couple of years later (Freedberg, 1940), which found a 
population of gastric cancer victims to have been colonised by spirochetes in 37% of all 
cases. But when in 1954 an extensive study of 1000 gastric biopsy specimens revealed no 
correlation between gastric cancer, ulcers of both the stomach or the duodenum and 
spirochetes, interest in the bacteriology of the stomach faltered and waned. 
 
Other paths of research were paving the way for the discovery of Helicobacter pylori. In 1924 
urease activity in the stomach was first described by Luck et al., but they were unable to 
elaborate on its function. A generation later Fitzgerald et al., 1950 suggested that urease 
activity protected gastric mucosa by mediating a reaction between urea and hydrogen ions, 
thus neutralising gastric acid by producing ammonia. They even went so far as to administer 
urea to test subjects in order to prove the validity of their theory. The bacterial origin of 
gastric urease was demonstrated by Delluva in 1968, when the absence of urease could be 
proven by testing germ free animals as urease negative.  
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Both areas and the symptomatic treatment of ulcer patients found its culmination in Marshall 
and Warren’s discovery of Helicobacter pylori in 1982. 
 
For the past decades ulcer patients had been treated according to the dictum by the Croatian 
physician Karl Schwarz (1910) ‘No Acid, No Ulcer’. New effective treatments such as 
stilboestrol and H2-receptor antagonists were at hand in the sixties and seventies. But, they 
had to be taken for life, since upon cessation of therapy ulcers would invariably reappear. 
 
In 1975 spiral bacteria were reported in association with gastritis in 80% of  gastric resection 
specimens from patients with gastric ulceration (Steer et al., 1975), but culture proved 
unsuccessful. Four years later similar bacterial specimens were found in the luminal surface 
of epithelial cells of gastric ulcer patients (Fung et al., 1979): Concerned largely with the 
correlation of endoscopic, histological and ultrastructural findings in chronic gastritis the 
bacteria were noted in passing. 
 
This was the professional environment that Professor Robin Warren, a histopathologist at the 
Royal Perth Hospital in Western Australia worked in at the time. In 1979 he had begun to 
notice that curved bacteria were often found in gastric biopsy specimens taken from patients 
with gastritis submitted for histological examination when slides were stained with the 
Warthin-Starry agent. These organisms were not present within the gastric mucosa, but lay in 
the mucus layer above the tissue (Marshall, 1989). Correlating these findings with previous 
reports encouraged further research. The problem at the time was that of unsuccessful 
culturing which had frustrated scientists previously working in that field, the bacteria had 
been left aside until generations of physicians forgot about it. Barry Marshall, a second year 
medical internist, became interested in Prof. Warren’s findings and they began a research 
project in 1981 with the goal of isolating and culturing the bacteria. Since the bacteria were 
curved, Gram-negative, microaerobic rods they used culture protocols applied to the isolation 
of the Campylobacter species which they closely resemble. Initially without success. They 
were however reassured that they were on the right track when Marshall successfully treated 
an elderly Russian suffering from gastritis and having histologically proven infestation with 
spiral bacteria with tetracycline. Symptoms failed to return after cessation of therapy. 
 
Progress on culturing the spiral bacteria continued to be unsuccessful. One Easter holiday 
culture plates were left in an incubator by mistake and on return almost discarded, because the 
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Campylobacter-specific protocols used had a three-day incubation period and they had been 
locked in for two days too many. To their surprise and delight they found that growth had 
occurred and they now had visible colonies of the bacteria they were looking for. In the 
following months they successfully isolated strains of bacteria from biopsy samples of 11 
patients with gastric disease using the new protocol. 
It was considered that they had enough material to present their findings on the relation 
between these Campylobacter-like organisms and intestinal disease to a wider audience. The 
1982 conference of the Royal College of Physicians was the venue for their presentation and 
not surprisingly it evoked mixed feelings in the assembly. The association of the bacteria with 
chronic active gastritis, peptic ulceration and possibly gastric adenocarcinoma was first 
published in letter form in 1983, then in the seminal work ‘Unidentified curved bacilli in the 
stomach of patients with gastritis and peptic ulceration’ in the Lancet in 1984, where they 
proposed to call them Campylobacter pyloridis. 
The medical community at large was not easily convinced of the notion that peptic ulcers 
were supposedly of bacterial origin. Previously it had been considered that an imbalance of 
acid production in the stomach somehow related to a dysfunction of the stomach itself was the 
cause, and an external pathogen did not fit the picture. More work was needed to provide 
unequivocal proof.  
In the same year, Rollason’s et al., 1984, a retrospective study of 310 endoscopic gastric 
biopsies, revealed 42% histological correlation of gastritis and existence of Campylobacter 
pyloridis, these being confined to the surface of the glands and epithelium. The following year 
Marshall (Marshall et al., 1985) supplied a study on two years biopsy samples of the gastric 
antrum which were cultured for C. pyloridis, detecting it in 88% of patients with 
histologically confirmed gastroduodenal disease and providing negative cultures for all 
patients with normal mucosa. He argued that pyloric Campylobacter infection be a major 
factor in the development of dyspeptic disease and peptic ulcer. Marshall provided himself 
with the ultimate argument in favour of pathogenicity of C. pyloridis by attempting to fulfil 
Koch’s postulates for an infectious agent. The healthy young man had biopsy-proven normal 
gastric tissue before the experiment, but after oral ingestion of pure cultured bacteria he 
developed a mild illness which lasted for 14 days; he experienced a light fever, tiredness and a 
loss of appetite. Histology done on a biopsy taken at the tenth day after ingestion showed 
gastritis but this had largely resolved by the fourteenth day. It was proposed that had C. 
pyloridis not been eradicated using antibiotics the chronic infection would have led to peptic 
ulceration (Marshall et al., 1985). 
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In another study (Goodwin et al., 1986) lesions found in histological samples of C. pyloridis-
infected stomachs were compared to those produced by enteropathogenic Escherichia coli and 
found to be similar. Goodwin also noted that the bacterium possessed a unique ultrastructure 
as well as singular fatty acids that separate it from all other Campylobacter strains. 
 
Its role as a pathogen secure, studies showing its association with various diseases continued 
to underscore the relevance of C. pyloridis. During a 12 month follow-up to eradication 
therapy for duodenal ulcers Coghlan et al. showed  in 1987 that culturable C. pyloridis was a 
significant predictor for success or failure of treatment. 79% of patients who remained culture 
positive had a relapse, but only 27% of culture negative patients suffered the same fate. These 
findings were supported by Marshall 1988, Borody 1990 and Patchett 1992. 
Gastritis-association was further corroborated by Hazell in 1987, when he found that the 
active chronic gastritis type B was limited to the antrum and the body of the stomach 
(reviewed in Marshall 1990). 
 
In the meantime Campylobacter pyloridis underwent some changes in nomenclature. In 1987 
its name was changed from the grammatically incorrect Campylobacter pyloridis to 
Campylobacter pylori (Marshall et al., 1987), then in 1989 there were considered to be 
enough singular features about it to create a new genus in its name: Helicobacter, from the 
Greek helical, as in spiral, and bacter, a staff, to describe its two most prominent features. 
Campylobacter pylori became Helicobacter pylori. The genus Helicobacter has since grown 
by adding novel species both in human and animal hosts. 
 
The early nineties brought new evidence for old suspicions, gastric carcinoma and 
Helicobacter pylori were strongly associated in a study conducted on Japanese Americans in 
Hawaii (Nomura et al., 1991). Serum samples of 5908 men taken between 1967 and 1970 
were tested for antibodies to Helicobacter pylori and correlated to the 109 cases of 
histologically confirmed gastric carcinoma. They found that even though the control group 
had 76% Helicobacter pylori positive sera the patients suffering from gastric carcinoma were 
95% positive. These findings were mirrored in further studies (Forman et al., 1991; Parsonnet 
et al., 1991/1997). 
In addition Helicobacter pylori has been associated with B-cell-lymphoma of the mucosa 
associated lymphoid tissue (MALT) indigenous to the intestinal tract (Wotherspoon et al., 
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1991) and controversially even with ischemic heart disease (IHD) (Mendall et al., 1994; 
Pellicano et al., 1999). 
It has been argued that eradication of Helicobacter pylori would lead to the increase of 
gastroesophageal reflux disease (GERD), basing this assumption on the observation that in the 
western world Helicobacter pylori infection is statistically sinking and GERD is on the 
increase (Blot et al., 1991). It has also been argued that infection with CagA positive strains of 
Helicobacter pylori reduced the risk of developing oesophageal and gastric cardial cancer 
(Chow WH et al. 1998). Both studies and others would imply that Helicobacter pylori was not 
simply a pathogen but also held a protective function in the human intestinal tract. This has 
been vehemently rejected by some authors (Axon, 1999) and been countered with the results 
of other studies such as a study done in Japan (Murai et al., 2000), where no increase of reflux 
oesophagitis, a prerequisite for oesophageal cancer, was found in Helicobacter pylori negative 
individuals.
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2.2 What is Helicobacter pylori? 
 
Helicobacter pylori is the best known member of the genus Helicobacter that consists of 18 
species, only few of which are known to be human pathogens. They are Gram-negative, 
microaerophilic, flagellated and are either curved rods or in spiral form. Key features ascribed 
to the genus are, amongst others, the presence of sheathed flagella, a G+C content of the 
chromosomal DNA which averages at 35.2 mol% (Beji et al., 1988) and the existence of a 
glycocalix. 
 
Helicobacter pylori is 0.5-0.9µm wide by 2-4µm long, has 4-6 unipolar flagella, a glycocalix 
roughly 40 nm thick (Goodwin et al., 1987/1990) and has its genome arranged in a single 
circular molecule that varies in size between 1.6 to 1.73 Mb (Beji et al., 1988). 
 
In vivo Helicobacter pylori is actively motile, in culture it can undergo morphological change 
to coccoid form, which is associated with lowered cultivability and has controversially been 
argued to represent a dormant state as a reaction to a hostile environment (Bode et al., 1993; 
Nilius et al., 1993). Its metabolism appears to be respiratory (Mendz et al., 1991), but has yet 
to be completely elucidated. 
Most notable biochemically is the abundant production of urease. This enzyme is initially 
intracellular and is later secreted by altruistic autolysis, an interesting mechanism in itself. 
When mucous gastric membranes are colonised, some of the bacteria die releasing urease and 
other outer membrane proteins (OMP) which then dissipate (Dunn et al., 1997), the 
transformation of urea to ammonia in the surrounding tissue providing an effective shield 
against gastric acid. This was proven in 1990 (Marshall et al., 1990) by exposing urease-
negative bacteria and Helicobacter pylori to acidic environments in combination with urea. 
Only Helicobacter pylori survived. Therefore urease is an essential factor for the survival of 
Helicobacter pylori in the strongly acidic environment of the stomach. 
 




Although 40% of isolated Helicobacter pylori contain one or more plasmids, these do not 
appear to encode any virulence factors (Kleanthous et al., 1991; Minnis et al., 1995). 
Genetic variation on all levels of the genome is well documented (Jiang et al., 1996). It 
displays an apparently endless macro- and microdiversity, while the phenotype itself remains 
relatively stable. 
Comparison of the genetic maps of five Helicobacter pylori strains demonstrated that there is 
no characteristic arrangement or clustering of 17 known genes (Jiang et al., 1996). This 
diversity is underscored by the fact that while VacA and others are always present, many 
genes, among them such markers of pathogenicity as CagA, can be present or not (Cover, 
1997; Murali et al., 1993; Censini et al., 1993). 
Both these genes are good examples of the amount of alleles found to be in existence during 
Helicobacter pylori research. When CagA was first described (Censini et al., 1993; Murali et 
al., 1993), one of the questions sought to be answered was whether the similar but 
inconsistently built genes associated with pathogenicity could effectively be grouped into one. 
Both research teams succeeded in doing so, showing that CagA had many alleles. The 
acronym stands for ‘cytotoxin associated gene’, for even though CagA is secreted into the 
host, they did not find the product to be toxic in itself. It has however been shown that it is 
frequently associated with diseases such as gastric- and duodenal ulcers and gastric cancer. 
VacA stands for ‘vacuolating cytotoxin’, for its product induces vacuolisation in gastric 
epithelial cells (Cover et al., 1997), which may ultimately lead to ulcers. This gene exhibits so 
called mosaicism, having to date four different families (s1a, s1b, s1c, s2) and two different 
families of middle-region alleles (m1, m2) (Cover et al., 1997). The genetic pattern of the 
VacA gene has been correlated with the presence of various illnesses, as demonstrated in 
various studies in different countries (Atherton et al., 1997; Letley et al., 1998; Evans et al., 
1998; van Doorn et al., 1998). They also showed that different alleles of VacA seem to have 
different effects on the population of different countries. 
The arrangement of genes of five isolates mapped by PFGE (pulsed field gel electrophoresis) 
have been analysed by Jiang (Jiang et al., 1996) revealing that there is little conservation of 
gene location among the strains. This is in marked contrast to other bacteria such as 
Escherichia coli and Salmonella typhimurium (Krawiec et al., 1990). 
To date the genomes of two strains of Helicobacter pylori have been sequenced in their 
entirety and an analysis as to their similarity was published in 1999 (Alm et al., 1999). 
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According to this paper the overall diversity in Helicobacter pylori has been misinterpreted 
due to an unavailability of two complete strains, stating that only 6-7% of genes are specific 
to each strain and almost half of those genes being clustered in a single hypervariable region. 
Comparing its results to Mycobacterium tuberculosis (Fleischmann RD et al., published 2002) 
the authors can however determine a nucleotide polymorphism in Helicobacter pylori two to 
three orders of magnitude higher than that of Mycobacterium tuberculosis, again upholding its 
immense variability. 
In population genetic studies (Achtman et al., 1999; Suerbaum et al., 1998) it has been shown 
that strain diversity in Helicobacter pylori has arisen as a result of recombination between 
strains and that new recombinant genotypes continue to be generated in patients infected with 
multiple strains. This was further demonstrated by Kersulyte et al., 1999. In a Lithuanian 
patient with a proven long-term infection with two parent strains six different variations of the 
two could be found using PCR, hybridization and DNA sequence-based evidence. 
 




Helicobacter pylori has been found in the stomachs of humans the world over and is one of 
the most common pathogens known to man. In developing countries large sections of the 
population can be infected, despite which the disease to infection ratio stays quite small: 
Research conducted on 177 Helicobacter pylori positive male subjects in India shows a point-
prevalence of 7.8% active ulcer disease (Khuroo et al., 1989), similar numbers are reported in 
other articles. This relatively low number must be seen in the relation of prevalence, which is 
exceedingly high. 
Factors promoting infection with Helicobacter pylori, so-called risk factors, are much sought 
after and many have been promoted. The most important and almost universally confirmed 
risk factor in the acquisition of Helicobacter pylori is low socio-economic status. In a recent 
sero-epidemiological study of 11'605 sera collected from all age groups and social classes in 
Mexico, Torres (Torres et al., 1998) could confirm these findings. A co-twin study (Malaty et 
al., 1999) could demonstrate that hygiene standards rather than genetic profiles of carriers 
were responsible for infection. Other risk factors include large families (Kikuchi et al., 1998) 
and parents history of gastric disease (Brenner et al., 1998). More controversial discussion has 
been held on the subject of gender and race. Male gender seems to be a significant risk factor 
in western countries (Lin et al., 1998). Afro-American children suffered more infections with 
Helicobacter pylori over a study interval of 12 years than a group of Anglo-Americans 
observed in the same community for the same period of time (Malaty et al., 1999). 
Prevalence can range from few percentage points to major parts of the population, even within 
single countries there are large variations. England has many communities of predominantly 
immigrant or native inhabitants. In an interesting study conducted in central England southern 
Asian immigrants and their children born in England were found to have a significantly 
higher rate of infection (47%) than a similar control group of native English people (15%). It 
can be postulated that Helicobacter pylori is transmitted in a family setting and that following 
that logic families would all be infected with similar strains of the bacteria. 
Transmission of Helicobacter pylori has been studied extensively, but no conclusive results 
have been found. As it has been isolated from animals such as cats (Neiger et al., 1998), 
contamination via animal spreading has been discussed. Hypothesizing that common 
houseflies have contact with human excretions and have been proven to transmit other 
diseases a study performed in Boston (Grubel et al., 1997) was successful in culturing 
Helicobacter pylori from both the surface and the gut of flies that were exposed to it after a 
controlled period of time. Evidence of Helicobacter pylori by PCR amplification has been 
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found in water, food and soil, but no culture has ever been successful using these as 
inoculation material. Consequently, the most popular theory is that it is transmitted gastro-
orally. Luzza (Luzza et al., 2000) proposes that Helicobacter pylori is transmitted in a family 
situation through vomiting of smaller children and contamination of others. Children were 
recruited and selected according to a so-called vomiting index. Results show that siblings of 
children with a high vomiting index have an increased risk of suffering from active infection. 
This would also help to explain the early age of infection that has been reported in developing 
countries (Rothenbacher et al., 2000). 
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2.5 Strain typing 
 
The methods used in molecular genetics have handed medical researchers a powerful tool in 
their quest to cure disease. Genetic fingerprinting is the most reliable way of identifying a 
pathogen, be it bacterial, viral or inherited, and can be of invaluable help in epidemiological 
study, creating new diagnostic approaches and furthering the development of new treatments. 
The idea is to access a pathogen’s genome in such a way that each can be distinguished from 
even its closest relative. A selection of the most common methods is given in Table 1 in the 
appendix section. 
The method of choice for us was the amplification of genes using the “polymerase chain 
reaction” with following restriction using “random fragment length polymorphism” (PCR-
RFLP). In 1996 Kansau et al. found it to be superior to the RAPD (random amplified 
polymorphic DNA) technique when they tested patients with gastritis before treatment and 
after unsuccessful treatment or relapse. It had the advantage of being selective in the section 
of gene targeted and being more easily reproducible. 
Burucoa (Burucoa et al., 1999) performed a combination analysis using experimental results 
as well as raw-data from literature and performed a meta-analysis of PCR-RFLP, ribotyping 
and RAPD. Concerning discriminatory power and typeability, the ability to give unequivocal 
results on analysis, PCR-RFLP succeeded in surpassing both remaining candidates. It was 
therefore proposed that PCR-RFLP should be the method of choice for the DNA-based 
differentiation of Helicobacter pylori. 
An interesting question was posed in a prospective study by Jeen (Jeen et al., 2001). After 
identical treatment with triple therapy some dyspepsia patients experience relapse. In this 
study, 10 patients were chosen with relapse after 6-24 months, another 10 patients with 
unsuccessful treatment and relapse on cessation of therapy were added as a control. In order 
to differentiate between recurrence of previous infection and re-infection with an alternate 
strain of Helicobacter pylori PCR-RFLP was used on biopsy samples from both pre- and 
post-treatment gastroscopies. Where most strains were identical in both pre- and post-therapy 
samples, the group with relapse after 6-24 months showed a higher incidence of infection with 
new strains as differentiated by PCR-RFLP. 
PCR-RFLP uses so-called profiles, describing both the segment of the genome targeted in the 
PCR amplification process and the restriction enzyme used in the following analysis. Owen 
(Owen et al., 1998) used an UreAB/NdeII profile in order to separate 383 samples obtained 
from 10 different countries. Using this profile they defined 82 different RFLP patterns of 
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which the ten most common patterns accounted for 51% of all samples. Only 18% of the 
samples had unique RFLP patterns leaving a vast amount of multiple band patterns from 
strains harvested from unrelated patients. Some of the sample bacteria that were considered to 
be genetically identical exhibited different levels of virulence in vivo. Maybe there is some 
other factor influencing those supposedly identical organisms, something in the patients 
alimentary habits, smoking, weight, genetic constitution, etc.. Maybe, however, the organisms 
may only seem to be identical in the one fingerprint that was taken. In a bacterium as 
genetically diverse as Helicobacter pylori this of course begs the question; Is there such a 
large amount of genetic homogeny or is the test not precise enough? This was what we 
wanted to put to the test, our reasoning being that additional testing was required if one set of 
PCR-RFLP presented us with data that described strains as identical that showed different 
levels of in-vivo virulence. If one set of fingerprinting with one gene allows a certain amount 
of discrimination then a combination with a second set of fingerprinting using a second gene 
should result in higher differentiation. 
Typing in itself is work-intensive and the information gleaned from it must be transferred to 
paper or be digitized for the sake of preserving it since the agarose gels can not be stored for 
any length of time. A database-program such as GelComparII (Applied Maths, Belgium) is an 
ideal way of storing not only the derived data from a PCR-RFLP-run but the data itself by 
digitizing the band patterns and sorting them by strain. This has not been widely performed or 
at least published, a Medline search revealed only 22 results to the search term GelComparII. 
A study done by Kivi (Kivi et al., 2003) on the concordance of Helicobacter pylori strains 
within families used GelComparII to map the interrelatedness of the different strains obtained 
by different family members. They showed that GelComparII defined roughly 25% more 
strains as singular than visual inspection, emphasizing that visual inspection of strain 
definition and correction of automatically assigned bands was essential even after utilizing all 
normalization and filtering techniques available in the program. The importance of visual 
inspection of all digitized and computer-sorted data is seconded in an article comparing two 
different database and interpretation programs done by Gerner-Smidt (Gerner-Smidt et al., 
1998) stating that both programs, though performing well, require the user to make critical 
decisions in the analysis. 




Helicobacter pylori is one of the most common pathogenic bacteria in the human body and 
has been found around the world. Its abundance and its association with important and 
widespread illnesses has been demonstrated. Research into this pathogen must be pursued if 
eradication or at least management is to be achieved. This is even more important since 
treatment will not be able to be effected via widespread use of antibiotics indefinitely, sooner 
or later other methods of treatment will have to be available to counter resistance developed in 
such a versatile organism. Antibiotics being costly current treatment is not an option for 
developing nations that have to harshly limit expenditure on the medical sector. Alternative 
treatment strategies will be essential if science wants to be fair to all nations. 
 
Understanding more clearly which organisms have which effect on the human body is 
essential for progress in this area. Fingerprint typing using PCR-RFLP is a viable and 
reproducible way of differentiation between strains as well as establishing links between 
phenotype and genotype, as has been demonstrated in many studies. 
 
Typing of Helicobacter pylori strains and classification according to virulence would offer 
physicians worldwide an alternative to simply treating every case of Helicobacter pylori 
infection as is standard practice today. They could choose to treat only virulent strains 
antibiotically, which would again reduce the amount of resistance developed by the bacteria 
and facilitate treatment if it was necessary. Later on, this list of virulent strains could be 
adapted for any population or race, if necessary. 




The reason the research in this paper was performed was to find an efficient and practicable 
method of genetically differentiating Helicobacter pylori strains found in gastric biopsy 
samples. 
Of the previously described methods PCR-RFLP was selected as the most viable test as it has 
been proven to be effective in differentiation in many studies and has the advantage of being 
reliably reproducible. 
The objective of this paper is to prove that two PCR-RFLP’s using two separate genes are 
superior to the single run in differentiation. 
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4. Materials and methods 
 
The Helicobacter pylori strains used in this study were isolated from tissue samples of patient 
gastric tissue harvested in biopsy form during endoscopic procedures in the University 




Half of each sample was spread onto Wilkins-Chalgren-Agar (Life Technologies) containing 
both Skirrow’s antibiotics (Vancomycin 10 mg/l, Cefsulodin 2 mg/l, Trimethoprim 5 mg/l, 
Actidion 100 mg/l) and 5% sheep-blood (BAG Med. AG, CH), while the other half was 
stored at -70°C. The plates were placed in an incubator at 37°C in a microaerophilic, water-
saturated atmosphere (created by CampyPak, Becton Dickinson) for 3 – 4 days, then checked 
for growth. If growth was present the clusters were subcultured onto the same media to 
increase bacterial yield and eliminate contaminants, if not, they were left for an additional two 
days. When ready, bacteria were harvested and collected in 500 µl of TE buffer (50 mM Tris 
HCl, pH 8.0, 1 mM EDTA). This mixture was suspended by vortexing. 
 
4.2 Phenol/Chlorophorm extraction 
 
Cells were harvested in a table top centrifuge at 8000 rpm at room temperature for 5 minutes, 
the supernatant poured off and another 500 µl of TE buffer added before resuspension by 
vortexing. 20 µl of lysozyme (1 mg/ml H20, Boehringer Mannheim) was then added and the 
mix incubated for 30 minutes at 37°C. After further addition of 5 µl of proteinase K 
(20mg/ml, Boehringer Mannheim) solution, 30 µl of 10% SDS (Sodium Dodecyl Sulphate) 
and 45 µl of TE buffer we repeated the incubation at 37°C for 2.5 hours. 100 µl of NaCl (5M) 
and 80 µl of pre-warmed CTAB (Cetyl tri methyl ammonium bromide, 10% in 0,7 M NaCl, 
SIGMA) were then added before further incubation at 65°C for 10 minutes, after which 780 
µl of chloroform/isoamyl alcohol (SIGMA) were mixed in by slow inversion. Centrifugation 
(Biofuge fresco, Heraeus) followed at 14’000 rpm for 10-15 minutes at 4°C, then the 
supernatant was carefully aspirated. The procedure was repeated with 750 µl of 
phenol/chlorophorm (SIGMA), supernatant again aspirated carefully and 640ml of 
isopropanol (SIGMA) added. After gentle mixing the sample was stored at –20°C for two 
hours. Centrifugation at 14'000 rpm for 20-30 minutes at room temperature was the next step 
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in order to precipitate the DNA, which was thereafter washed with the same volume of 70% 
ethanol under the same conditions. In order to dry the DNA pellet, the samples were placed in 
an exsiccator  connected to a vacuum pump (KNF Neuberger Lavoport 
Membranvakuumpumpe) for 10-15 minutes. Finally 50 µl of TE buffer were added to DNA 
for conservation purposes. 
 
4.3 PCR amplification  
 
UreAB and UreCD were chosen as target genes because they are found in every strain of 
Helicobacter pylori. 
The primers used are listed in Table 2 in the appendix section. 
 
Amplification of UreAB was carried out in 100 µl using 2.5 µl template DNA from 
Helicobacter pylori isolates, 2 x 2 µl of each primer (100 nmol/ml, Microsynth CH), 2 µl 
dNTP (10 mM each, Boehringer Mannheim), 2 µl hot-start taq-polymerase (1 U / µl, 
QIAGEN), 8 µl MgCl2 (25 mM stock solution, QIAGEN), 10 µl buffer (25 mM, Boehringer 
Mannheim) and 71.5 µl of sterile Millipore water. For UreC-UreD 4 µl of MgCl2 was found 
to be sufficient for optimal amplification, which brought the amount of distilled water up to 
75.5µl to account for the difference in volume. PCR was performed in a Techne Progene PCR 
cycler (Witec AG, CH). Details of protocol are given in Table 3 in the appendix section. 
 
The resulting product was tested by running an agarose-gel electrophoresis. A 1.2% agarose 
gel was created by using Life Technologies agarose and a 10 fold concentrated TPE buffer (1 
litre contained 108.0g of Trisbase (SIGMA), 29.78g of Na2-EDTA 2H2O (SIGMA), sterile 
water and the pH was brought to 7.6 using the appropriate amount of H3PO4 (MERCK)). The 
gel was poured into a 7x11 cm well, left to set and then immersed in the same TPE buffer, 
three wells were filled with 25 µl of each product (with the addition of 5 µl of loading buffer 
(33% glycerine, 7% SDS, 0.07% bromophenolblue in sterile water)). After running, staining 
with ethidiumbromide (10µg/ml) and viewing in a Vilber Lauromat UV transilluminator 
(wavelength 254 nm) the relevant bands were excised for further processing. 
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4.4 DNA extraction from Gel 
 
DNA was extracted from the gel using the QIAamp Gel Extraction Kit (QIAGEN AG, CH). 
In compliance with the manufacturers manual TE buffer was added to the gel-bound excised 
bands and were spun for 15 mins at 4°C with 13‘000 rpm. All fluid was poured off, leaving 
only a solid pellet at the bottom of the vial. 100 µl of ATL buffer as well as 40 µl of 
proteinase K stock solution (20 mg/ml) were added and the mix incubated at 55°C overnight 
in an Eppendorf thermomixer (400 rpm). 20 µl of RNase A (20mg/ml, Boehringer 
Mannheim) was added the following day to rid the mix of possible RNA-contamination, the 
vial was then vortexed and incubated at room temperature for 2 minutes. Addition of 200 µl 
of buffer AL, vortexing  and incubation at 70°C for 10 minutes followed, whereupon 210 µl 
of >98% ethanol were added before repeated vortexing. The QIAamp spin columns were 
filled with the mixture and, with a 2 ml collection tube as receptacle. All of the following 
centrifugation steps were performed at room temperature. Centrifugation at 8000 rpm for 1 
minute was performed (Heraeus Biofugue tabletop cooled centrifuge). The QIAamp column 
was placed in a fresh collection tube, 500 µl of buffer AW poured into the spin column and 
centrifugation repeated at 8000 rpm for 1 minute. A new collection tube was used and 500 µl 
of buffer AW placed in the spin column once again and the mix centrifuged for three minutes 
at 13'000 rpm. Then the QIAamp spin column with the extracted DNA was placed into a 
clean 1.5 ml (or 2 ml) microfuge tube, 210 µl of buffer EB heated to boiling point and 100 µl 
of it added to the QIAamp column. Centrifugation was done at 8000 rpm for 1 min, after 
which the process was repeated. The DNA was then ready to be precipitated from the buffer 
EB. The mix was transferred to a 1.5 ml Eppendorf cup and 3 M sodium acetate (Boehringer 
Mannheim) – 10% of the mix volume – and twice the mix-volume of 100% absolute alcohol 
(SIGMA) were added, the resulting solution stored at -4°C overnight. The next morning all 
samples were centrifuged with 13'000 rpm at 4°C, the remaining fluid was discarded and the 
pellets dried in a vacuum for 10 minutes, before being redissolved in 24 µl of sterile H2O. 
This mix was the basis for digestion. 
 
4.5 Restriction of PCR products 
 
UreAB was digested using HaeIII (Boehringer Mannheim, 10U/µl). 1 µl of HaeIII was added 
to 10 µl of PCR-product together with 1.2 µl of the provided optimal reaction buffer M. This 
mix was left at 37°C overnight in a theramablock (Eppendorf Thermomixer comfort). The 
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following day electrophoresis was performed using a 2% agarose gel in order to separate the 
resulting restriction bands. These gels were stained using ethidium bromide and Polaroid 
photographs were taken. UreCD was digested using 0.5 µl NdeII (5U/µl, Boehringer 
Mannheim) and 10 µl of the provided special buffer to 10 µl of the PCR-product. The rest of 
the procedure was the same as with UreAB. 
 
4.6 Evaluation of gel patterns 
 
All Polaroid pictures of gels were analysed conventionally in comparison to the standardised 
bands that were also run with the samples during testing. An example of the Polaroid results 
can be seen in Figure 1 in the appendix section. The base-pair sizes of each fragment after 
both PCR- and restriction-runs were entered into Table 2 and Table 3 and can also be seen in 
the appendix section. 
The Polaroid pictures were scanned (Figure 1) for evaluation in Applied Maths’ (Belgium) 
GelComparII program. The bands corresponding to a biopsy sample were electronically 
separated from the gel it was run on (Figure 2) and a database built from individual band-
structures (Figure 3). The bands on the patterns are then marked automatically by the 
computer program and their size correlated to standard size bands that ran with the 
corresponding gel in order to account for inequalities in gel structure and act as reference 
points. After calibration the relationship between the band patterns can be assessed and are 
graphically displayed (Figure 4). 
This was done for both PCR-RFLP runs and the two graphs were then compared as further 
described in the results section. 




Of the 37 frozen biopsies from unrelated patients 33 samples were successfully cultured, 4 
resisted culturing. All 33 samples allowed amplification and restriction of both the UreAB and 
the UreCD segment of the genome with HaeIII and NdeII respectively. 
 
Two different analyses of the Polaroid pictures of the ethidium bromide stained 
electrophoresis gels (samples of which are pictured in Figure 7 and Figure 8) were 
performed, both a conventional visual approach and a computerized assessment of 
interrelatedness using GelComparII (Applied Maths, Belgium). 
 
The results of visual analysis have been grouped in Table 4 and Table 5. 
The UreAB/HaeIII restriction yielded a total amount of 20 band patterns with 10 patterns 
encompassing 2 or more stains. 10 strains were found to be singular. 
UreCD/NdeII was less discriminatory in this experiment showing only 14 band patterns in 
total with 4 band patterns having 2 or more samples attributed to them. As in the 
UreAB/HaeIII run 10 singular band patterns were found (Table 7). 
Combining the results of both the UreAB/HaeIII and the UreCD/NdeII runs leaves two 
strains, strains 4 and 37 identical in both runs (Table 6), all other strains could be clearly 
defined into singular organisms. Table 6 also shows the pattern-partners of each strain in all 
four variants of analysis. 
 
UreAB/HaeIII as analyzed by GelComparII shows a higher differentiation into a total of 30 
band patterns with only 2 patterns with 2 or more samples attributed to them. 
As expected from conventional visual analysis UreCD/NdeII is less discriminatory showing a 
total of 23 band patterns and 5 pattern with 2 or more strains attributed to them (Table 7). 
Combining the two PCR-RFLP runs leaves no strain grouped to another, in effect all strains 
have been defined as singular. 
 
In the UreCD/NdeII run GelComparII shows 5 band patterns with 2 or more strains attributed 
to them whereas the visual analysis shows only 4. This is attributable to the fact that a strain 
defined as singular in the visual analysis (strain 2) is grouped to another strain (strain 22) 
which, contrary to visual analysis, is not grouped in the largest of multiple strain patterns. 
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This leads to an additional subgroup and a higher number of strain patterns with 2 or more 
strains. 
 
With this exception all strains both in the UreAB/HaeIII and the UreCD/NdeII PCR-RFLP 
runs are consistently grouped into the same band patterns both in visual analysis and in 
GelComparII interrelatedness assay (Table 6). The large difference in the amount of band 
patterns between visual and GelComparII analysis is due to GelComparII defining more 
strains as singular than was considered correct during visual assessment. 
 
When on final analysis all results are pooled more weight was given to visual analysis than 
GelComparII as advised by literature (Gerner-Smidt et al., 1998) and two strains (strains 4 
and 37 as marked in Table 6) remained identical in both UreAB/HaeIII and UreCD/NdeII 
PCR-RFLP runs and were therefore considered to be the same strain of Helicobacter pylori. 
 
The sum of the base-pair (bp) sizes of the restriction bands of an individual restriction run are 
expected to correspond to the total bp size of the section of Genome in question. In 
UreAB/HaeIII the sum was smaller than expected in 2 strains (3 and 10) and larger in 3 (20, 
26 and 33). UreCD/NdeII also showed 2 smaller than expected total bp counts, strains 24 and 
36, 2 strains were larger than expected (26 and 33) (Table 4 and 5). 
Only samples 26 and 33 were larger than expected in both restrictions, all smaller than 
expected samples were unique to one restriction run. These two samples are hypothesized to 
contain two separate strains of Helicobacter pylori. 
 
During the normalisation routine while digitizing the Polaroid pictures of PCR-RFLP patterns 
into GelComparII much care was taken to correct the automatically assigned bands using both 
the Polaroids themselves and the previously performed visual analysis. After normalisation all 
patterns looked visually identical, no unexpected bands could be newly defined. The 
difference in evaluation using GelComparII or visual approach derives purely from slight 
variations in estimation of individual bp sizes of the bands. 




The success of this experiment is the fact that almost complete differentiation of every patient 
sample into a singular strain could be performed using two gene loci for PCR and an 
individual restriction protocol with visualisation using gel electrophoresis. Using either of the 
two amplification-restriction protocols was not sufficient, both amplification-restriction 
protocols had to be combined as described in the results section. As all patients were 
unrelated and did not know each other this could be expected and would be consistent with 
the genetic variability of Helicobacter pylori. The one remaining pair of strains (numbers 4 
and 37 as marked in Table 6) identical in both restrictions is acceptable and also to be 
expected, as identical strains are bound to exist following transmission from one person to 
another. 
The two analyses of the UreAB/HaeIII and UreCD/NdeII protocols, i.e. manual/visual and 
with the GelComparII software, differed in result most notably in that GelComparII did not 
find strains 4 and 37 to be identical. Whereas manual evaluation always gives space for and 
necessitates interpretation of results at every level, defining band sizes, lenience for 
electrophoresis-gel-warping, etc., GelComparII is much more rigid. After scanning the bands 
some correction for gel warping can be performed and some correction of the automatic 
allocation of bands can be done (Gerner-Smidt et al., 1998). These are by definition manual 
steps and have the same inherent faults as pure visual evaluation. Where GelComparII 
becomes more rigid than visual evaluation is in the definition of levels of interrelatedness of 
the strains; after exact definition of each band of each strain there is little allowance for gross 
similarity, the patterns are grouped according to strict protocol. This protocol can be adapted 
with the addition of certain lenience percentages to correct for obvious mistakes, but is the 
inherent difference in the two evaluation methods. 
This explains why the GelComparII results in Tables 6 and 7 show more unique band 
patterns. The obvious advantage to GelComparII is that it allows the comparison of hundreds 
or even thousands of band patterns and the building of intra- and inter-laboratory databases. 
In keeping with literature (Kivi et al., 2003) visual evaluation was taken as the gold standard 
and results were interpreted accordingly. 
 
After adding all bands of each strain they were compared to the expected size of the UreAB or 
UreCD loci as a control feature. As described in the results chapter some were smaller and 
some larger than expected. The differences in size that were only registered in one of the two 
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runs were considered to be erroneous, an error in measuring or evaluation must have occurred 
that led to the deletion or addition of bands. Another explanation for the size-difference could 
be double-bands where two fragments of almost equal size appear to be hidden in one 
appearing ‘thicker’ (more fluorescent) than normal. This would be very difficult to detect in 
the current experimental setting. 
Two strains, numbers 26 and 33, that were larger than expected in both PCR-RFLP runs 
remained. These two patients were considered to be infected with two different strains of 
Helicobacter pylori showing some overlap in band-size which accounts for the fact that the 
expected total size of the genes is not double the norm. Colonization of individuals with more 
than one strain of Helicobacter pylori appears to be rare among Europeans and North 
Americans. Taylor (Taylor et al., 1995) found more than one colonizing strain in only three 
out of 15 patients and Marshall (Marshall, 1996) found only one out of 19 patients to be 
infected with two strains. In sharp contrast developing countries such as Peru can show a 
double infection rate of up to 34% (Berg et al., 1997). 
 
As does any method of research our applied method of culturing with following PCR-RFLP 
has its disadvantages. The most obvious ones would be faults in transportation, handling and 
storage as well as human error in all steps of analysis. The most notable weaknesses can be 
differentiated into two sections; culturing, not dependent on skill, where 4 samples were lost 
due to no growth, and the analysis of the Polaroid pictures of the electrophoresis gels which is 
very dependent on skill and experience. Some variation in thickness in the gels used to 
separate the bands electrophoretically is to be expected. This leads to warping of the band 
patterns of the restricted PCR products which can at times become rather extensive. It can be 
countered by repeated running of PCR-RFLP products which is very time- and cost- intensive 
in both equipment and manpower or, as performed here, with the addition of a computer 
program such as GelComparII which has an inbuilt function to straighten the bands according 
to the simultaneously run standardised bands as described in the results section. All these 
correction methods are however at times arbitrary and rely heavily on the experience and 
precision of the researcher.  
 
In an insightful article in Science magazine Daniel Falush et al. (Science 2003) recently 
harvested 370 strains from 27 geographical and ethnic human groupings and using the 
sequenced information of seven housekeeping genes, one virulence associated one (VacA) and 
a computer program called ‘structure’ presented a history of human and Helicobacter pylori 
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migration. The program analysed all sequenced bacteria and grouped them into four modern 
populations, which were then subdivided into a total of seven major populations. It could be 
proven that Helicobacter pylori has been associated with humans for such a long time that the 
interrelatedness of the strains corresponds to the migration of humans from continent to 
continent up to and including the slave-trade from Africa to America and Europe. 
 
This experiment would like to be seen in the light of continuing important research into the 
nature of Helicobacter pylori. We set out to prove that the combination of multiple PCR-
RFLP’s with multiple genes was superior to the single protocol performed on any one strain. 
The breaking up of the grouped strains by the second PCR-RFLP into new groups or singular 
profiles, as shown in Table 6, resulted in a markedly superior differentiation of strains. In 
consequence we propose that no analysis of Helicobacter pylori should be based on one 
method of differentiation alone. An ideal combination of tests would be capable of 
definitively differentiating between two strains of Helicobacter pylori. If this idea would be 
extrapolated to its maximum potential a database of the genotypes of known strains could be 
correlated with the phenotype, i.e. the virulence of the strain itself. This would enable the 
precise administration of antibiotic drugs where necessary and would help curtail both the 
development of resistance towards these medications and reduce the costs to society, therefore 
increasing the population that could afford to get effective treatment for their illness.





Short introduction to selected methods of genetic differentiation (so-called fingerprinting) 
 
TECHNIQUE EXPLANATION 
Culture Mixtures of bacteria are reared on media that select for a specific bacteria. As they each have 
their own way of metabolising substances they need, have their own favourite culture conditions 
and show differences in their resistance to antibiotics, separation of bacteria can be achieved 
through the choice of supplied nutrients, given pH-value or other conceivable valuables (Hachem 
et al., 1995) added to the media the bacteria is allowed to grow on. 
It is very cost- and time-intensive as it requires incubators, specific media and surrounding 
atmospheres and time to await results as well as personnel to run the laboratory. There is only 
limited possibility for separating one strain of bacteria from another, such as when alleles encode 
for basic functions. Though not strictly speaking a method of genetic fingerprinting, it is widely 
used for differentiation of known organisms on the species level and is mentioned in that light. 
PCR (polymerase chain reaction) PCR is widely used in the scientific community as a method for amplifying defined sections of 
DNA. If for example a single known gene is to be amplified by a pair of primers, single stranded 
inverse copies of the initial sequences of the target gene, as read on both complementary sides of 
the DNA-strand in question, also known as the template, is produced to act as a key. The primers 
are added to a mixture of heat-resistant DNA-polymerase, nucleotides, buffer and Magnesium. 
This mixture is then heated in order to separate the double-stranded DNA. During the cooling 
process that follows, the primer is able to anneal with the appropriate complimentary sequence of 
the gene, the polymerase picks up where the primer ends and extends the primers with the 
provided nucleotides; the gene is replicated. After renewed heating the copy is separated from the 
original single strand and the amount of gene available has been doubled. These steps are called 
one cycle and after many cycles the gene in question has been amplified exponentially. PCR is 
capable of amplifying a single gene to such numbers that testing becomes possible and has 
therefore become indispensable in the world of genetics. 
PFGE (pulsed-field-gel-electrophoresis) A section of DNA is digested by restriction endonucleases, enzymes that can recognise certain 
successions of nucleic acids within which they cut the strand. PFGE allows the resulting DNA 
fragments to be separated by the inherent negative charge of the phosphate groups. The samples 
are placed in little slots in agarose-gel (or any other kind of gel), the gel immersed in a buffer 
fluid and an electric current applied in such a way that the nucleic acid strands migrate through 
the gel. The mesh-like structure of the gels allows their passage, whereby larger strands travel 
slower than shorter ones separating them according to size. The resulting patterns can be 
visualised using ethidium bromide or other nucleic acid dyes (Jiang et al., 1996). 
Ribotyping Ribosomal RNA-molecules (rRNA) are found universally and exhibit a highly conserved 
structure. This method requires an organisms strands of nucleic acids, both chromosomal and 
ribosomal, to be digested by nucleases and the resultant to be separated by PFGE. The resultant 
gels can be hybridised using radioactively marked DNA or RNA probes, depending on the 
questions to be asked 
Phylogenetic analysis and the creation of orders of bacteria has been one of the major fields of its 
implementation. It has also been successfully used in a clinical setting to type the Helicobacter 
pylori strains of pre- and post-therapy non-responders, which were found to be identical (Rautelin 
et al., 1994). 
RFLP (restricted fragment length 
polymorphism) 
Chromosomal DNA is digested by restriction endonucleases and separated by fragment size via 
gel electrophoresis. The resulting fragments are hybridized with DNA probes called primers 
made from known genes carrying a marker. During hybridization the primers bind to their genetic 
counterpart and allow further differentiation by use of their attached marker. This method has 
been used to construct a genetic map for Helicobacter pylori, which turned out to be a good 
example for the large inner-species variability at a genetic level (Taylor et al., 1992). 
PCR-RFLP A specific gene is amplified using PCR. The resulting yield is digested by restriction 
endonucleases and the fragments separated by gel electrophoresis. This method enables research 
into allelic variation, which is one of the keys to differentiation. PCR-RFLP has been proven to 
be effective in typing strains and provides a reliable test for future reference (Akopyanz et al., 
1992, Foxall et al., 1992).  
RAPD (random amplified polymorphic 
DNA) 
Short single primers are added to a PCR mixture and PCR is performed. As opposed to PCR-
RFLP this does not result in a specific and continuous product, random annealing at 
corresponding areas of the genome occurs and creates a number of variously sized fragments. 
These are however specific to a strain of bacteria. Because the methodology relies on the PCR 
creating many different fractions that would enable differentiation size becomes critical.  
RAPD has been used successfully in distinguishing between clinical isolates (Akopyanz et al. 
1992). 
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Direct PCR The biopsy samples have their DNA extracted directly, without any culturing of bacteria. This 
method is highly sensitive but requires a very well thought-out and tested PCR protocol because 
of the amount of interfering DNA contained in the sample. Hennig et al. examined in 1999 the 
presence of CagA and VacA in patients with either duodenal ulcer (DU) or gastritis (G). They 
found a definite positive association for CagA and the s1 genotype of the VacA gene with DU 
patients. 
Sequencing of genome DNA is subjected to a treatment similar to PCR. The same sequence of heating, annealing and 
replication is performed with the difference that the normal nucleotides are exchanged for altered 
ones that, when incorporated into a strand halt production. All four “defective” nucleotide types 
are labelled and can be recognised by the wavelength of the light they emit when subjected to 
laser lighting. All strands will have very different lengths and their respective ends will be the 
only thing labelled. By separating them electrophoretically on a polyacrylamid-gel the exact 
position in the strand can be found and all positions can be traced. 
Knowing the exact sequence of a genetic strand is the ultimate information gainable for genetic 
research. This is however immensely time- and cost-intensive and not feasible in everyday 
research. To date only two strains of H. pylori have been sequenced completely (Alm RA et al. 99 
Nature) and surprisingly showed a large overall genetic similarity. 
PCR-DNA sequence typing A specific gene is amplified via PCR and then typed by direct DNA sequencing. If the chosen 
gene was a very common gene, such as in the case of Helicobacter pylori the one for urease, it 
could be sequenced for all known strains and biopsy bacteria could be correlated with a database 






Sense 5‘- AGG AGA ATG AGA TGA –3‘ 
antisense 5‘- ACT TTA TTG GCT GGT –3‘ 
Expected fragment size 2.4 kb Foxall et al., 1992 
UreC-UreD 
Sense 5‘- TGG GAC TGA TGG CGT GAG GG –3‘ 
antisense 5‘- ATC ATG ACA TCA GCG AAG TTA AAA ATG G –3‘ 
Expected fragment size 1.7 kb Labigne et al., 1991 
 
Primers used for amplification 
 
Table 3 
PCR cycling protocol used for amplification of both UreAB and UreCD 
 
1.segment 95°C for 5 mins  1. cycle 
2. segment 85°C for 1 min Stop to add taq 
1. segment 94°C for 1 min  
2. segment 45 / 
60°C 
for 1 min repeat cycle 2. x 35 
2. cycle 
3. segment 72°C for 2.5 / 1.5 mins  
3. cycle  72°C for 10 mins  
4. cycle  4°C Loop End of protocol  





Manual readout of the UreAB/HaeIII restriction grouped into highlighted band-types. 
The numbers in the left column correspond to patient/strain numbers, the fragment-sizes of each 
individual patient are listed horizontally, with the sum of all fragments listed in the column on the 
far right. 





No 80 160 180 200 230 270 300 320 340 450 510 530 620 700 1220 sum
14 180 200 320 340 700 1740
21 180 200 320 340 700 1740
30 180 200 320 340 700 1740
16 180 230 300 340 530 1580
17 180 230 300 340 530 1580
32 180 230 300 340 530 1580
3 180 340 510 530 1560
8 180 340 510 530 1560
10 180 340 510 530 1560
19 180 340 510 530 1560
4 180 340 530 700 1750
6 180 340 530 700 1750
7 180 340 530 700 1750
9 180 340 530 700 1750
12 180 340 530 700 1750
15 180 340 530 700 1750
18 180 340 530 700 1750
20 180 340 530 700 1750
22 180 340 530 700 1750
23 180 340 530 700 1750
31 180 340 530 700 1750
35 180 340 530 700 1750
37 180 340 530 700 1750
26 180 230 300 340 530 700 2280
13 180 230 300 340 700 1750
29 180 230 270 300 340 450 1770
25 180 200 300 340 530 1550
28 80 180 340 530 620 1750
33 180 340 510 530 700 2260
2 200 340 530 700 1770
24 160 180 340 530 1210
34 180 340 1220 1740
36 180 200 340 700 1420
 
Manual readout of the UreCD/NdeII restriction grouped into highlighted band-types. 
The numbers in the left column correspond to patient/strain numbers, the fragment-sizes of 
each individual patient are listed horizontally, with the sum of all fragments listed in the 
column on the far right. 
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Table 6 
Conventional  GelComparII Conventional GelComparII Patient/strain 
number Identical band patterns in 
UreAB/HaeIII digestion 
Identical band patterns in 
UreCD/NdeII digestion 
2 19 Singular Singular 22 
3 Singular Singular 8, 10, 19 8, 10 
4 37 Singular 6, 7, 9, 12, 15, 18, 20, 
22, 23, 31, 35, 37 
7, 12, 18, 23, 31 
6 36 Singular 4, 7, 9, 12, 15, 18, 20, 
22, 23, 31, 35, 37 
9 
7 30 Singular 4, 6, 9, 12, 15, 18, 20, 
22, 23, 31, 35, 37 
4, 12, 18, 23, 31 
8 13, 32 Singular 3, 10, 19 3, 10 
9 14, 16, 17 14, 16 4, 6, 7, 12, 15, 18, 20, 
22, 23, 31, 35, 37 
6 
10 Singular Singular 3, 8, 19 3, 8 
12 Singular Singular 4, 6, 7, 9, 15, 18, 20, 
22, 23, 31, 35, 37 
4, 7, 18, 23, 31 
13 8, 32 32 Singular Singular 
14 9, 16, 17 9, 16 21, 30 Singular 
15 34 Singular 4, 6, 7, 9, 12, 18, 20, 
22, 23, 31, 35, 37 
Singular 
16 9, 14 9, 14 17, 32 Singular 
17 Singular Singular 16, 32 Singular 
18 Singular Singular 4, 6, 7, 9, 12, 15, 20, 
22, 23, 31, 35, 37 
4, 7, 12, 23, 31 
19 2 Singular 3, 8, 10 Singular 
20 Singular Singular 4, 6, 7, 9, 12, 15, 18, 
22, 23, 31, 35, 37 
37 
21 22 Singular 14, 30 Singular 
22 21 Singular 4, 6, 7, 9, 12, 15, 18, 
20, 23, 31, 35, 37 
2 
23 Singular Singular 4, 6, 7, 9, 12, 15, 18, 
20, 22, 31, 35, 37 
4, 7, 12, 18, 31 
24 29, 35 Singular Singular Singular 
25 33 Singular Singular Singular 
26 Singular Singular Singular Singular 
28 Singular Singular Singular Singular 
29 24, 35 Singular Singular Singular 
30 7 Singular 14, 21 Singular 
31 Singular Singular 4, 6, 7, 9, 12, 15, 18, 
20, 22, 23, 35, 37 
4, 7, 12, 18, 23 
32 8, 13 13 16, 17 Singular 
33 25 Singular Singular Singular 
34 15 Singular Singular Singular 
35 24, 29 Singular 4, 6, 7, 9, 12, 15, 18, 
20, 22, 23, 31, 37 
Singular 
36 6 Singular Singular Singular 
37 4 Singular 4, 6, 7, 9, 12, 15, 18, 
20, 22, 23, 31, 35 
20 
Evaluation of band-patterns in both conventional manual and GelComparII analysis. 
Highlighted are the two only identical strains relying on manual analysis. 
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Table 7 
UreAB/HaeIII UreCD/NdeII  
manual GelComparII manual GelComparII 
Total amount of 
Band patterns 
20 30 14 23 
Band patterns with 
2 or more strains 
10 2 4 5 
Singular band 
patterns 
10 28 10 18 
 
Number of band patterns after analysis. 
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Figure 1 
Example of gel-electrophoresis run with restricted PCR-amplified segments of H. pylori DNA  
 
 
The nucleic acids in the DNA wander from the wells through the gel towards the anode, the 




Electronically separated band 
 
Using Applied Maths’ program bands can be separated from the photos of electrophoresis 




First step in evaluation with Applied Maths’ GelComparII program 
 
The bands highlighted by ethidium bromide are registered by the program and sorted 
according to base-pair-size. In this graph all patient samples are listed, ordered horizontally, 
displaying all band-sizes shown after restriction. 
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Figure 4 
Result of analysis by GelComparII 
 
 
After the last step of analysis, definition and correction of automatically assumed fragment-
sizes, this is the resulting chart. From left to right three different graphs are shown, the middle 
one corresponding to Figure 3. On the right are shown the standardized boxes indicating the 
different fragment-sizes in each gel-electrophoresis analysed (strains ordered horizontally, 
size increasing from left to right). This graph is then used by GelComparII to create the graph 
on the far left, a tree showing the genetic similarity and assumed interrelatedness of all 
samples on which this restriction was performed. 
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Figure 5 
Full printout after analysis of the UreAB/HaeIII restriction band-patterns by GelComparII 
 
Details are given in the figure itself; the chart represents a printout of all data available after 
analysis in GelComparII (Applied Maths, Belgium), the numbers correspond to patient 
samples. 
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Figure 6 
Full printout after analysis of the UreCD/NdeII restriction band-patterns by GelComparII 
 
Details are given in the figure itself; the chart represents a printout of all data available after 
analysis in GelComparII (Applied Maths, Belgium), the numbers correspond to patient 
samples. 




Scanned Polaroid pictures of a selection of band patterns after UreAB/HaeIII digestion 
samples were subjected to gel electrophoresis and ethidium bromide staining, numbers 
corresponding to patient samples. 




Scanned Polaroid pictures of a selection of band patterns after UreCD/NdeII digestion 
samples were subjected to gel electrophoresis and ethidium bromide staining, numbers 
corresponding to patient samples. 
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